Business leader responsible for consistent double digit growth of Research Instruments platform (~$350M/Year) comprised of flow cytometers, cell sorters and sample prep solutions.Managed a global, cross functional team to deliver customer focused solutions around the world. Directly manage leaders and a large group of extended business team members and support functions.Established the strategic direction for the Research Instrument portfolio, including Flow Cytometers & Cell Sorters, and owned execution of the global strategy across functions and regional business teams to advance areas of research in oncology and immunology. Led global commercialization and successful launch of 3 new instruments in less than 3 years. Executed a successful awareness and funnel generation campaign across multiple geographies, while conducting daily management of development team deliverables for operational readiness and release of new instruments into production.Created new market research approaches, like virtual focus groups, to adapted to pandemic era restrictions, while gathering critical business insights to inform business strategy, development roadmaps and competitive analysis.

Responsible for growing ~$80M P&L, establishing organizational priorities and deployment of resources.Managed team of 19 people including Marketing, Technical Support and Service departments for a broad portfolio of fluidic component and automation product lines, such as pumps, valves, and sample prep instrumentation.Acquired and fully integrated a new complimentary business (Pulssar Technologies) & completed full manufacturing transfer in 7 months, while maintaining existing customers and growing the business. Restructured the customer facing organization from product oriented individuals to customer centric teams to improve the customer experience and deliver exciting new products.Created and executed the marketing communications strategy generating 40% increase in leads, 50% increase in opportunities and aligning channels with changing demographics and expectations. Developed new business models by expanding service offerings, adding new revenue and profit streams that improve customer loyalty and satisfaction.

Managed all marketing activities and personnel for a broad portfolio of fluidic component product lines, such as pumps, valves, and fluidic assemblies, across multiple manufacturing locations (~$80M/Year). Led the strategic planning process for the Life Science business unit resulting in significant sales growth and profit improvements.Restructured the marketing department to align with company and life science strategies, including new role definitions, recruitment, procedures, and team culture.Executed marketing communications plan, generating multi-million dollar wins in targeted markets, including micro-fluidic point of care, mass spectrometry, and DNA sequencing.

Responsible for all commercial aspects of most recent acquisition in territory (Americas). Doubled sales in assigned territory in < 1 year and established executive level relationships with target customers that generated significant growth and new product development successes.

Provided market analysis critical to organic and inorganic growth strategies. Delivered key inputs to leadership, product management, and commercial teams, as a member of the front-end planning team, enabling long-term results in total market sales and growth.Launched a platform of biocompatible liquid products, including tubing, fittings, columns, pumps and valves, to accelerate growth in mass spectrometry proteomics / metabolomics research and IVD markets.

Supported due diligence activities, acquisition, and integration of largest direct competitor.Created the new commercial strategy for integrating ERC, Inc. into IDEX Health and Science (~$41M/Year).Supervised and trained marketing specialists.

Captured new opportunities and grew degasser product line revenues rapidly through the release of line extension products (~$12M/Year to ~$25M/Year).Updated new product development roadmap and coordinating technology acquisition activities for the product line.Created new sales and marketing tools to communicate technology benefits and value to customers.Updated product development roadmap and supported technology acquisition activities for the product line.

Analyzed and determined investment opportunities for new products, which led to product margins and ROIs above company and industry averages.Doubled product line revenues in less than two years time through the release of valuable new products and gaining of market share.Increased product line gross margins from 23% to 47% through successful cost reduction programs, new product releases, and outsourcing production to low cost partners.Coordinated all aspects of three new product launches including customer qualifications and planned obsolescence programs.

Developed new technologies for gas purification and related applications. Participated in the design and implementation of manufacturing processes, instrumentation, and equipment from the laboratory through pilot plant and release to manufacturing. Assisted manufacturing operations in problem solving and improved product quality. Published research in industry magazines and presented at technical conferences. Lowered detection limit of analytical instruments to obtain a competitive advantage.Trained new engineers and technicians on equipment and procedures.

Managed materials development laboratory, maintained complex capital equipment, and completed several successful research experiments.Worked in the R&D department assisting chemical engineers with test design and removal of impurities from high pressure gases. Experienced with fluid delivery design, setup and system use. Analyzed and compared various media such as molecular sieves for development of semiconductor purifiers.Operated and maintained the following equipment types: gas chromatographs, ion chromatographs, mass spectrometers, FTIRs, trace moisture and oxygen probes, mass flow controllers, and many others.